Ebola virus

Definition

Ebola virus is an infectious agent and one of the viruses that can cause haemorraghic fever, a severe infectious disease characterized by high fever and bleeding, in humans and some monkeys. The first infections with this viral genus were reported in Zaire, close to the river Ebola.

Latest Research and Reviews

  • Research |

    Near-atomic resolution cryo-electron microscopy structures of the Zaire ebolavirus nucleoprotein indicate a complex transition from the RNA-free to RNA-bound forms of the protein, and reveal the mechanism of oligomer formation and helical assembly.

    • Yukihiko Sugita
    • , Hideyuki Matsunami
    • , Yoshihiro Kawaoka
    • , Takeshi Noda
    •  & Matthias Wolf
    Nature 563, 137–140
  • Reviews |

    The virulence of viruses is a major determinant of the health burden of viral infections in humans and other species. In this article, Geoghegan and Holmes discuss how largely disparate research fields — theoretical modelling of virulence evolution and experimental dissection of genetic virulence determinants in laboratory model systems — can be bridged by considering real genomic data of viral evolution in a phylogenetic context. They describe the underlying principles of virulence evolution and how they apply to real-world viral infections and outbreaks of global importance.

    • Jemma L. Geoghegan
    •  & Edward C. Holmes
  • Research | | open

    The Ebola virus glycoprotein is a target for cross-protective antibodies. Here, Janus et al. report the crystal structure of the antigen-binding fragment of a pan-reactive antibody bound to a conserved epitope of the glycoprotein, facilitating rational design of cross-protective vaccines and therapeutics.

    • Benjamin M. Janus
    • , Nydia van Dyk
    • , Xuelian Zhao
    • , Katie A. Howell
    • , Cinque Soto
    • , M. Javad Aman
    • , Yuxing Li
    • , Thomas R. Fuerst
    •  & Gilad Ofek
  • Research |

    Genomic characterization of a new ebolavirus, detected in free-tailed bats in Sierra Leone, whose viral glycoprotein can mediate entry into human cells.

    • Tracey Goldstein
    • , Simon J. Anthony
    • , Aiah Gbakima
    • , Brian H. Bird
    • , James Bangura
    • , Alexandre Tremeau-Bravard
    • , Manjunatha N. Belaganahalli
    • , Heather L. Wells
    • , Jasjeet K. Dhanota
    • , Eliza Liang
    • , Michael Grodus
    • , Rohit K. Jangra
    • , Veronica A. DeJesus
    • , Gorka Lasso
    • , Brett R. Smith
    • , Amara Jambai
    • , Brima O. Kamara
    • , Sorie Kamara
    • , William Bangura
    • , Corina Monagin
    • , Sagi Shapira
    • , Christine K. Johnson
    • , Karen Saylors
    • , Edward M. Rubin
    • , Kartik Chandran
    • , W. Ian Lipkin
    •  & Jonna A. K. Mazet
    Nature Microbiology 3, 1084–1089
  • Reviews |

    Efforts towards developing post-exposure therapies for infections with filoviruses, particularly Ebola and Marburg viruses, increased substantially during the Ebola virus outbreak of 2013–2016. Geisbert and colleagues review the progress made on this front and discuss the challenges and opportunities for developing post-exposure therapies in the future.

    • Robert W. Cross
    • , Chad E. Mire
    • , Heinz Feldmann
    •  & Thomas W. Geisbert

News and Comment